Purchase Order 75N91024P00127

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $13,557.12 firm fixed price purchase order to Molecular Devices LLC for maintenance services. The contract has a period of performance from January 1, 2024 through December 31, 2024. Molecular Devices LLC will provide maintenance for equipment located at the NIH campus in Bethesda, Maryland in support of the NCI's research programs. No subcontractors or set aside designations were...

Molecular Devices LLC was awarded a $10,217 firm fixed price purchase order for maintenance services by the National Institutes of Health's National Cancer Institute. The contract has no set-aside designation and work is to be performed in San Jose, California through March 7, 2025. As a provider of bioanalytical measurement solutions, Molecular Devices will support the National Cancer Institute's research efforts through the delivery of maintenance for laboratory instruments and equipment.

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $13,711 purchase order to Molecular Devices LLC for maintenance services. Molecular Devices, located in Bethesda, Maryland, will provide maintenance under a firm fixed price contract to support the agency's research efforts. No subcontractors or set aside designations were identified. The award falls under HHS-NIH's efforts to advance cancer research and further the National Cancer...

This firm fixed-price purchase order contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Molecular Devices LLC, a for-profit limited liability company that manufactures bioanalytical measurement solutions. The $10,217.00 maintenance agreement contract does not have a set-aside designation and has a performance period ending on March 31, 2025. Molecular Devices has previously provided specialized laboratory...

The Department of Health and Human Services' National Institutes of Health's National Institute of Neurological Disorders and Stroke awarded a $205,543 firm fixed price purchase order to Molecular Devices LLC for a maintenance and service agreement for an ImageXpress Micro confocal high-content imaging system. The place of performance will be Molecular Devices LLC's San Jose, California facility. The agreement runs from November 2020 through November 2024 to provide support for the imaging...

This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Molecular Devices LLC, a manufacturer of bioanalytical measurement equipment. The $10,217.00 contract is for the maintenance of laboratory instruments, equipment, software, and related services. This contract does not have a set-aside designation. Molecular Devices LLC has a history of providing specialized...

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $14,555 purchase order to Molecular Devices LLC for a service agreement for the SpectroMax i3x plate reader. The contract has a period of performance from December 15, 2023 through December 14, 2024 and utilizes a firm fixed price pricing structure. Molecular Devices LLC will provide plate reader services from its Rockville, Maryland location to support the National Cancer Institute's...

This contract was awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Molecular Devices LLC, a provider of high-performance bioanalytical measurement solutions. The $7,821.75 firm fixed price purchase order contract is for the provision of laboratory instruments, equipment, software, maintenance, and related services to support the agency's healthcare research and public health initiatives. This award did not have a small business...

This is a $10,217 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation. The contract is for a service agreement with an ultimate completion date of August 8, 2025. Molecular Devices is a leading provider of bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development. The company often receives sole-source awards as the original...

This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Molecular Devices LLC, a division of Danaher Corporation, for a service agreement with a potential value of $10,217.00. The contract does not have a set-aside designation and is scheduled for completion on June 8, 2025. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement solutions, such as...